BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4629907)

  • 21. Deoxyribonucleic acid strandedness. Partial characterization of the antigenic regions binding antibodies in lupus erythematosus serum.
    Samaha RJ; Irvin WS
    J Clin Invest; 1975 Aug; 56(2):446-57. PubMed ID: 125288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
    Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes.
    Morimoto C; Sano H; Abe T; Homma M; Steinberg AD
    J Immunol; 1982 Nov; 129(5):1960-5. PubMed ID: 7119438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of soluble immune complexes by the technique of ADCC inhibition in human diseases.
    Meyer O; Descamps B
    J Clin Lab Immunol; 1979 Nov; 2(4):311-8. PubMed ID: 537026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera.
    Shrier DA; Taniguchi O; Barnett EV
    J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.
    Adu D; Dobson J; Williams DG
    Clin Exp Immunol; 1981 Mar; 43(3):605-14. PubMed ID: 6974627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum anti-dsDNA antibodies in lupus nephritis].
    Fiorentini GP; Cagnoli L
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1890-5. PubMed ID: 7032540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA anti-dsDNA antibodies in systemic lupus erythematosus: occurrence, incidence and association with clinical and laboratory variables of disease activity.
    Miltenburg AM; Roos A; Slegtenhorst L; Daha MR; Breedveld FC
    J Rheumatol; 1993 Jan; 20(1):53-8. PubMed ID: 8441166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunopathologic mechanism in some ocular diseases].
    Rogoz S; Avramescu C; Siloşi I; Drackoulogona O; Badea P; State A
    Oftalmologia; 2002; 54(3):51-5. PubMed ID: 12723199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Prevalence of and relation to antibodies against DNA and extractable nuclear antigens.
    Gripenberg M; Piirainen H; Linder E
    Scand J Rheumatol; 1981; 10(1):33-7. PubMed ID: 6971488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rhupus: when rheumatoid arthritis meets lupus].
    Malaise O; Halleux S; von Frenckell C; Lutteri L; Chapelle JP; Malaise MG
    Rev Med Liege; 2012 Sep; 67(9):475-84. PubMed ID: 23115849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of anti-DNA antibody using synthetic antigens. Characterization and clinical significance of binding of poly (deoxyadenylate-deoxythymidylate) by serum.
    Steinman CR; Deesomchok U; Spiera H
    J Clin Invest; 1976 May; 57(5):1330-41. PubMed ID: 1262474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The search for circulating immune complex (IC) (author's transl)].
    Verroust P
    Ann Biol Clin (Paris); 1980; 38(6):333-43. PubMed ID: 7011116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillating levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient.
    Zouali M; Eyquem A
    Ann Immunol (Paris); 1983; 134C(3):377-91. PubMed ID: 6625532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.